Form 4: Silversmith Partners Reduces Stake in LifeStance Health Group

Silversmith Partners sold 1,624,638 shares of LifeStance Health Group at $5.89 per share on May 24, 2024, reducing their beneficial ownership.

Summary

• On May 24, 2024, Silversmith Partners I GP, LLC sold 1,624,638 shares of LifeStance Health Group (LFST) common stock.
• The sale price was $5.89 per share.
• Following the transaction, the Silversmith Entities (Silversmith Capital Partners I-A, L.P., Silversmith Capital Partners I-B, L.P., and Silversmith Capital Partners I-C, L.P.) indirectly hold 17,916,554 shares.
• The Silversmith Entities may be deemed a member of a 'group' under Section 13(d) of the Securities Exchange Act of 1934 due to a Stockholders Agreement with certain persons who are owners of more than 10% of the Issuer's outstanding common stock.

Sentiment

Score: 5

Explanation: Neutral sentiment. The document simply reports a transaction. The impact on the company is uncertain and depends on market reaction.

Negatives

• Silversmith Partners reduced their stake in LifeStance Health Group, which could be interpreted negatively by the market.

Risks

• The sale by a significant shareholder like Silversmith Partners could create downward pressure on the stock price.
• The 'group' status under Section 13(d) could trigger regulatory scrutiny or affect future transactions.

Industry Context

Sales by major shareholders are common and can reflect portfolio adjustments or changes in investment strategy. The impact on LifeStance Health Group will depend on market perception and overall investor sentiment towards the company and the behavioral health industry.

Comparison to Industry Standards

• It's common for venture capital and private equity firms like Silversmith Partners to reduce their holdings in portfolio companies after a certain period.
• The size of the sale (1,624,638 shares) is significant but not unusual for a firm with a large initial stake.
• Comparable transactions would include sales by major shareholders in other publicly traded healthcare companies, such as those in the behavioral health or telehealth sectors.

Stakeholder Impact

• Shareholders may react to the sale, potentially affecting the stock price.
• Employees may be indirectly affected by any resulting changes in company valuation or strategy.

Key Dates